DRG Market Assessment reports
Comprehensive market intelligence and actionable insights help you optimize your long-term disease strategy
Acute Myeloid Leukemia – Landscape & Forecast – Disease Landscape & Forecast (G7)
Acute myeloid leukemia (AML) is associated with poor outcomes and low five-year overall survival rates. Although chemotherapy has long been the mainstay of AML treatment, the recent approval of new…
Metabolic Dysfunction-Associated Steatohepatitis | Disease Landscape & Forecast | G7 | 2025
The market for metabolic dysfunction-associated steatohepatitis (MASH), previously known as nonalcoholic steatohepatitis (NASH), has great untapped potential owing to the disease’s high…